Deciphering the role of the GUT and tumor microbiome on ovarian cancer progression and resistance to chemotherapy

Active Project Grant Awarded Last action

Award ID
HT9425261E060
Recipient
Awarding agency
Obligated
$700,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 13% complete
Place of performance
Cleveland, OH 44195, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded The Cleveland Clinic Foundation $700,000 on May 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to investigate the role of the gut and tumor microbiome on ovarian cancer progression and resistance to chemotherapy. Work is performed in Cleveland, Ohio, with a period of performance extending through April 30, 2030. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative research and investigation of medical solutions for the battlefield and military operations.

Quick answers

Who received award HT9425261E060?

HT9425261E060 was awarded to The Cleveland Clinic Foundation by Defense Health Agency (Department of Defense) on May 1, 2026.

How much is award HT9425261E060 worth?

$700,000 has been obligated on HT9425261E060.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login